Works by Horvat, Reinhard


Results: 29
    1
    2

    The efficacy of trastuzumab in Her-2/ neu-overexpressing metastatic breast cancer is independent of p53 status.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2005, v. 131, n. 7, p. 420, doi. 10.1007/s00432-005-0670-3
    By:
    • Köstler, Wolfgang;
    • Brodowicz, Thomas;
    • Hudelist, Gernot;
    • Rudas, Margaretha;
    • Horvat, Reinhard;
    • Steger, Günther;
    • Singer, Christian;
    • Attems, Johannes;
    • Rabitsch, Werner;
    • Fakhrai, Negar;
    • Elandt, Katarzyna;
    • Wiltschke, Christoph;
    • Hejna, Michael;
    • Zielinski, Christoph
    Publication type:
    Article
    3
    4

    Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium.

    Published in:
    Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-67
    By:
    • Aust, Stefanie;
    • Auer, Katharina;
    • Bachmayr-Heyda, Anna;
    • Denkert, Carsten;
    • Sehouli, Jalid;
    • Braicu, Ioana;
    • Mahner, Sven;
    • Lambrechts, Sandrina;
    • Vergote, Ignace;
    • Grimm, Christoph;
    • Horvat, Reinhard;
    • Castillo-Tong, Dan Cacsire;
    • Zeillinger, Robert;
    • Pils, Dietmar
    Publication type:
    Article
    5
    6

    HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2013, v. 141, n. 1, p. 43, doi. 10.1007/s10549-013-2665-0
    By:
    • Lipton, Allan;
    • Goodman, Laurie;
    • Leitzel, Kim;
    • Cook, Jennifer;
    • Sperinde, Jeff;
    • Haddad, Mojgan;
    • Köstler, Wolfgang;
    • Huang, Weidong;
    • Weidler, Jodi;
    • Ali, Suhail;
    • Newton, Alicia;
    • Fuchs, Eva-Marie;
    • Paquet, Agnes;
    • Singer, Christian;
    • Horvat, Reinhard;
    • Jin, Xueguang;
    • Banerjee, Joyee;
    • Mukherjee, Ali;
    • Tan, Yuping;
    • Shi, Yining
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Fatty acid synthase is a metabolic marker of cell proliferation rather than malignancy in ovarian cancer and its precursor cells.

    Published in:
    International Journal of Cancer, 2015, v. 136, n. 9, p. 2078, doi. 10.1002/ijc.29261
    By:
    • Veigel, Daniel;
    • Wagner, Renate;
    • Stübiger, Gerald;
    • Wuczkowski, Michael;
    • Filipits, Martin;
    • Horvat, Reinhard;
    • Benhamú, Bellinda;
    • López‐Rodríguez, María Luz;
    • Leisser, Asha;
    • Valent, Peter;
    • Grusch, Michael;
    • Hegardt, Fausto G.;
    • García, Jordi;
    • Serra, Dolors;
    • Auersperg, Nelly;
    • Colomer, Ramón;
    • Grunt, Thomas W.
    Publication type:
    Article
    19
    20
    21

    Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients--a study of the OVCAD consortium.

    Published in:
    2013
    By:
    • Bachmayr-Heyda, Anna;
    • Aust, Stefanie;
    • Heinze, Georg;
    • Polterauer, Stephan;
    • Grimm, Christoph;
    • Braicu, Elena Ioana;
    • Sehouli, Jalid;
    • Lambrechts, Sandrina;
    • Vergote, Ignace;
    • Mahner, Sven;
    • Pils, Dietmar;
    • Schuster, Eva;
    • Thalhammer, Theresia;
    • Horvat, Reinhard;
    • Denkert, Carsten;
    • Zeillinger, Robert;
    • Castillo-Tong, Dan Cacsire
    Publication type:
    journal article
    22
    23
    24
    25
    26
    27

    HPV prevalence in vulvar cancer in Austria.

    Published in:
    Wiener Klinische Wochenschrift, 2017, v. 129, n. 21/22, p. 805, doi. 10.1007/s00508-017-1255-2
    By:
    • Pils, Sophie;
    • Gensthaler, Lisa;
    • Alemany, Laia;
    • Horvat, Reinhard;
    • de Sanjosé, Silvia;
    • Joura, Elmar
    Publication type:
    Article
    28
    29